Lindsey Allen - Amylyx Pharmaceuticals Head Communications
| AMLX Etf | USD 2.03 0.03 1.50% |
| Address | 43 Thorndike Street, Cambridge, MA, United States, 02141 |
| Phone | 617 682 0917 |
| Web | https://amylyx.com |
Amylyx Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0534 % which means that it generated a profit of $0.0534 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1273 %, meaning that it created $0.1273 on every $100 dollars invested by stockholders. Amylyx Pharmaceuticals' management efficiency ratios could be used to measure how well Amylyx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Lars MBA | PDS Biotechnology Corp | 54 | |
| Robyn MA | Acumen Pharmaceuticals | N/A | |
| Mark Winderlich | Hookipa Pharma | N/A | |
| Emil MD | Terns Pharmaceuticals | 43 | |
| Suba Krishnan | Mereo BioPharma Group | 59 | |
| Soojin Kim | Inozyme PharmaInc | N/A | |
| JD Esq | Acumen Pharmaceuticals | 53 | |
| Lauren MBA | Day One Biopharmaceuticals | 48 | |
| Jeffrey Jasper | Terns Pharmaceuticals | N/A | |
| Diana Chung | Terns Pharmaceuticals | N/A | |
| Sanjay Zaveri | PDS Biotechnology Corp | N/A | |
| Prof MD | Day One Biopharmaceuticals | 55 | |
| MBA MD | X4 Pharmaceuticals | 62 | |
| Adam Dubow | Day One Biopharmaceuticals | 57 | |
| Gregory Conn | PDS Biotechnology Corp | 69 | |
| Matthew Beck | Hookipa Pharma | N/A | |
| Robert Arbeit | X4 Pharmaceuticals | 76 | |
| Bo Kara | Mereo BioPharma Group | N/A | |
| Pharm MPH | X4 Pharmaceuticals | N/A | |
| Kirk MD | PDS Biotechnology Corp | 72 | |
| Roman Necina | Hookipa Pharma | 56 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0534 |
Amylyx Pharmaceuticals Money Managers
| Debra Canner, Global CHRO | ||
| Margaret MBA, Global Officer | ||
| Shauna Horvath, Head Marketing | ||
| Chris Aiello, Head GM | ||
| Justin Klee, CoCEO CoFounder | ||
| James MBA, Chief Officer | ||
| MD MBA, Global Officer | ||
| Tammy Sarnelli, Global Affairs | ||
| Joshua Cohen, CoCEO CoFounder | ||
| Tom Holmes, Chief Officer | ||
| Gina Mazzariello, Chief Counsel | ||
| Keith White, Head Access | ||
| Lindsey Allen, Head Communications | ||
| Linda Arsenault, Chief Officer |
Amylyx Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Amylyx Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0534 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | (229.07 M) | ||||
| Shares Outstanding | 68.01 M | ||||
| Shares Owned By Insiders | 15.11 % | ||||
| Shares Owned By Institutions | 84.89 % | ||||
| Number Of Shares Shorted | 6.51 M | ||||
| Price To Book | 0.32 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amylyx Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amylyx Pharmaceuticals' short interest history, or implied volatility extrapolated from Amylyx Pharmaceuticals options trading.
Pair Trading with Amylyx Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amylyx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Amylyx Etf
| 0.8 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.74 | ME | 23Andme Holding | PairCorr |
Moving against Amylyx Etf
| 0.86 | YS | YS Biopharma | PairCorr |
| 0.64 | DOMH | Dominari Holdings | PairCorr |
| 0.5 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
The ability to find closely correlated positions to Amylyx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amylyx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amylyx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amylyx Pharmaceuticals to buy it.
The correlation of Amylyx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amylyx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amylyx Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amylyx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amylyx Pharmaceuticals. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Amylyx Etf please use our How to Invest in Amylyx Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
The market value of Amylyx Pharmaceuticals is measured differently than its book value, which is the value of Amylyx that is recorded on the company's balance sheet. Investors also form their own opinion of Amylyx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amylyx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amylyx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amylyx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amylyx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amylyx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amylyx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.